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Available online 20 August 2014AbstractHypercalcemic crisis is a rare but life-threatening condition defined by decompensation of hypercalcemia with significant disturbance to
cardiac, renal, gastrointestinal and neurological function. Here we document the case of a 74-year-old gentleman with a parathyroid adenoma
who presented to hospital after bloods revealed severe hypercalcemia (5.58 mmol/L). Rehydration with diuretics and bisphosphonate infusions
failed to revert the hypercalcemia over 42 hours (5.58 mmol/L). Low calcium hemodialysis rapidly reduced calcium levels and allowed for
further investigations. Computerised tomography (CT) scan and magnetic resonance cholangiopancreatography revealed associated acute
pancreatitis. A parathyroid adenoma was discovered by ultrasound and removed surgically. Parathyroidectomy led to resistant hypocalcemia
requiring multiple calcium infusions. Hypercalcemia may lead to nausea and vomiting, decrease oral fluid intake and nephrogenic diabetes
insipidus. This in turn leads to volume depletion and hypovolemic acute kidney injury. In patients severe acute kidney injury leading to renal
failure, aggressive fluid replacement may be detrimental and these patients may require correction by dialysis. Literature review returned 13 case
reports/case series totalling 68 patients undergoing dialysis for hypercalcemia. These case reports found a rapid decrease in serum calcium levels
post calcium free hemodialysis (CFHD). Mortality was observed in only one case report which was attributed to sepsis.1 Hemodialysis
reportedly clears 682 mg/hr of calcium vs 82 mg/hr in saline diuresis.2 It offers a safe way of treatment in patients with cardiac and renal co-
morbidities and results in rapid reduction in calcium levels and improvement in cognition.1,3,4
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Hypercalcemic crisis is a rare, but life-threatening condi-
tion defined by decompensation of hypercalcemia with sig-
nificant disturbance to cardiac, renal, gastrointestinal, and
neurological function.
We document the case of a 74-year-old gentleman with a
parathyroid adenoma who presented to the hospital after blood
work revealed severe hypercalcemia (5.58 mmol/L).
Rehydration using intravenous fluids with diuretics and
bisphosphonate infusions failed to improve the hypercalcemia
over the course of 42 hours (5.58 mmol/L). Low-calcium* Corresponding author. 293 Nine Mile Ride, Finchampstead, Wokingham,
Berkshire, England RG403NS, UK.
E-mail address: rboulding@doctors.org.uk (R. Boulding).
http://dx.doi.org/10.1016/j.jacme.2014.06.003
2211-5587/Copyright © 2014, Taiwan Society of Emergency Medicine. Publishedhemodialysis rapidly reduced his calcium levels and allowed
for further investigation. Computerized tomography (CT) and
magnetic resonance cholangiopancreatography revealed asso-
ciated acute pancreatitis. A parathyroid adenoma was
discovered by ultrasound and removed surgically. Para-
thyroidectomy led to resistant hypocalcemia requiring multi-
ple calcium infusions.
Hypercalcemia may lead to nausea and vomiting, decreased
oral fluid intake, and nephrogenic diabetes insipidus. This, in
turn, leads to volume depletion and hypovolemic acute kidney
injury. In patients with severe acute kidney injury leading to
renal failure, aggressive fluid replacement may be detrimental,
and these patients may require correction by dialysis.
A literature review returned 14 case reports/case series
totaling 74 patients undergoing dialysis for hypercalcemia.by Elsevier Taiwan LLC. All rights reserved.
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levels after calcium-free hemodialysis. Mortality was observed
in two case reports: one was attributed to sepsis and the other,
to resistant hypercalcemia leading to ventricular fibrillation.1,2
Hemodialysis reportedly clears 682 mg/hour of calcium versus
82 mg/hour in saline diuresis.3 Hemodialysis offers a safe way
of treatment in patients with cardiac and renal comorbidities
and results in rapid reduction of calcium levels and improve-
ment in cognition.1,4,5
2. Case Report
A 74-year-old man presented to the hospital after a referral
from his general practitioner. He had visited his general
practitioner 2 days previously after his daughter reported
slurred speech, difficulty walking, and collapse. At home, the
patient was confused, aggressive, and unsteady. Prior to this,
the patient had been cognitively intact and active for his age.
Routine blood work was done, including a bone profile. His
corrected calcium level was 5.58 mmol/L, and he was advised
to report to the hospital immediately.
On arrival, the patient was confused, agitated, and dis-
oriented. He had been well 2 days prior to admission until he
had collapsed. A similar episode of hypercalcemia had
occurred in 2006, and the patient had been admitted to
intensive care but discharged himself after 5 days, prior to any
further investigations.
Initial vital signs were recorded as blood pressure of 161/
92 mmHg, heart rate of 88 beats/minute, respiratory rate of 14
breaths/minute, and oxygen saturation of 94% on room air. He
was apyretic with a normal blood sugar. He was hallucinating,
and examination revealed new onset atrial fibrillation, reduced
skin turgor, and dry mucous membranes. A neurological ex-
amination was difficult to perform, but deep tendon reflexes
remained intact.
A complete blood count revealed increased white blood
cells of 21.5  109/L, neutrophils of 18.98  109/L, and he-
moglobin of 154 g/L. Biochemistry revealed calcium of
5.58 mmol/L, urea of 11.7 mmol/L, creatinine of 161 mmol/L,
potassium of 3.1 mmol/L, and C-reactive protein of 10.9 mg/
L. Chest X-ray showed some minimal left side congestive
changes, and an electrocardiogram showed a shortened QT
interval, J waves in lead II, and new onset atrial fibrillation. A
full septic screen was performed, but results later showed no
bacterial growth in either urine or blood cultures; arterial
blood gases were PO2 10.1 kPa, PCO2 6.07 kPa, pH 7.39, and
base excess 4.5 mmol/L.
The patient was initially treated for hypercalcemia, sepsis
of unknown source, and acute kidney injury. Zolendronic acid
intravenous infusion, rapid rehydration with normal saline,
and cefuroxime as per microbiology guidelines were started.
The patient was prescribed 5 L of fluid over 24 hours,
catheterized for strict fluid input/output, placed on cardiac
telemetry, and had daily blood work. A CT scan of his brain
showed no acute pathology.
The following day, the patient had a deteriorated mental
state and reduced responsiveness although observationsshowed that his condition remained stable. Intravenous furo-
semide was prescribed, and he was given a further 5 L of fluid
over the course of the day.
After 42 hours, the patient had had a total of 7200 mL of
fluid input with 7075 mL total output. He remained confused
and agitated. His condition deteriorated, and the patient
became septic requiring 3 L of oxygen via nasal cannula.
His calcium level remained high with three consecutive
readings all >5 mmol/L during the first 42 hours. Inflamma-
tory markers were elevated with neutrophils of 28.14  109/L
and C-reactive protein 289 mg/L. The patient was started on
teicoplanin and gentamicin for presumed chest sepsis. A
bridled nasogastric tube was inserted to provide nutrition and
prevent hypophosphatemia.
The patient was immediately transferred to the dialysis
ward for 2 hours of hemodialysis with low calcium/high po-
tassium dialysate via a femoral line. His postdialysis calcium
was 3.13 mmol/L with rapid improvement in cognition
(Glasgow Coma Scale 14) and attempts made at
communication.
Further reduction of calcium was attempted by rehydration
with 4 L of normal saline daily and adjuvant furosemide. Once
stabilized, CT of the chest/abdomen/pelvis showed acute
pancreatitis (amylase, 58 m/L), and follow-up magnetic reso-
nance cholangiopancreatography showed no evidence of
gallstones. The patient's admission parathyroid hormone was
1.9 pmol/L but had risen to 120 pmol/L 10 days after
admission. A nuclear medicine parathyroid scan was clear, but
a follow-up parathyroid ultrasound revealed a
1.7 cm  1.6 cm  3.5 cm parathyroid adenoma at the inferior
pole of the left thyroid. Owing to ongoing hypercalcemia, the
patient required two more zoledronic acid infusions and a
second course of low calcium hemodialysis.
After parathyroidectomy, the patient suffered hypocalcemia
(1.7 mmol/L) and required multiple calcium infusions of 40 mL
of 10% calcium gluconate and adcal D3. Unfortunately, the pa-
tient discharged himselfwith resistant hypocalcemia (1.87mmol/
L) and failed to attend follow-up outpatient appointments.
3. Discussion
Calcium homeostasis is maintained mainly by parathyroid
hormone, which acts by aiding conversion of 25-
hydroxyvitamin D to 1,25-dihydroxyvitamin D in the kidney
and stimulates calcium reabsorption in the ascending loop of
Henle.6 The vast majority of the body's calcium is within the
bones and can be accessed by osteoclast activation. Only a
very small percentage of total body calcium contributes to
serum calcium levels, and it is protein bound and not bio-
logically active.
Hypercalcemia affects multiple organs and often presents as
polyuria and polydipsia, nausea, vomiting, and diarrhea, tired-
ness, and headache.7 In severe hypercalcemia termed “hyper-
calcemic crisis”, patients can present with oliguria and have
psychological disturbances or coma. The most common causes
of hypercalcemic crisis are primary hyperparathyroidism and
malignancy.8 Hypercalcemia is a presenting feature in up to 5%
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Parathyroid hormone or its related peptide can be directly
released by cancer cells or have local osteolytic affects.10,11
Treatment consists of aggressive rehydration therapy aim-
ing for input of 200e500 mL/hour depending on age, calcium
level, and comorbidities.12 Furosemide is still widely used in
view of its ability to increase diuresis although its use in
treatment of hypercalcemia lacks evidence.13 Bisphospho-
nates, particularly zoledronic acid, have been shown to be
superior to pamidronate at lowering calcium levels and
providing reductions in calcium levels over the course of 48
hours.14 During the first 48 hours, a rapid reduction in calcium
can be provided by calcitonin although its use is limited to this
period.15 Hemodialysis is indicated for resistant hypercalce-
mia and those with hypercalcemic crisis and renal failure.7
The definitive treatment is surgery in those patients with
parathyroid hormone-related hypercalcemia. Patients must be
adequately hydrated prior to and after surgery, and strict
monitoring of postsurgical calcium levels is essential. Hy-
percalcemic crisis remains one of the few indications for ur-
gent parathyroidectomy, and appropriate resection can keep
patients eucalcemic in the long term.16
It is important to note that patients presenting in hyper-
calcemic crisis are more likely to be male and have related
pancreatitis and significant alteration of mental state than
those presenting with mild to moderate hypercalcemia.17
Currently, the use of hemodialysis in hypercalcemia is
often reserved for those with renal failure or comorbidities that
contraindicate aggressive fluid management. There are
currently no guidelines for when dialysis should be consid-
ered, but the common consensus is when the glomerular
filtration rate falls below 10e20 mL/minute.12,18 This case is
an example of the use of low calcium hemodialysis in a hy-
percalcemic crisis with preserved renal function.
In summary, calcium-free hemodialysis is extremely
effective in treating hypercalcemic crisis, with a rapid reduc-
tion in serum calcium. It is safe in patients with both cardiac
and renal comorbidities as well as those with preserved renal
function. In patients with prolonged hypercalcemia and hy-
perparathyroidism, parathyroidectomy can lead to resistant
postsurgical hypocalcemia.
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